Daniel J. Müller

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 599 citations · Full text

Primary Tumour Subtype, Epidemiology, Cancer Epidemiology +11

Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process

Kelly E. Caudle, Teri E. Klein, James M. Hoffman et al. · Current Drug Metabolism · 2014 · 423 citations · Full text

Genetic Epidemiology, Pharmacotherapy, Genetic Medicine +18

Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy

Kristine R. Crews, Andrew A. Monte, Rachel Huddart et al. · Clinical Pharmacology & Therapeutics · 2021 · 366 citations · Full text

Clinical Pharmacogenetics Implementation Consortium Guideline for <i>HLA</i> Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

Elizabeth J. Phillips, Chonlaphat Sukasem, Michelle Whirl‐Carrillo et al. · Clinical Pharmacology & Therapeutics · 2018 · 285 citations · Full text

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

José de León, Georgios Schoretsanitis, Robert L. Smith et al. · Pharmacopsychiatry · 2021 · 234 citations · Full text